Treatment Response and Resistance in Schizophrenia (Oxford Psychiatry Library Series) by Unknown

Author:Unknown
Language: eng
Format: epub
Publisher: OUP Oxford
Published: 2018-09-19T16:00:00+00:00

References

Agid, O., Arenovich, T, Sajeev, G., et al. (2011). An algorithm-based approach to first-episode schizophrenia, response rates over 3 prospective antipsychotic trials with a retrospective data analysis. J Clin Psychiatry , 72, 1439–44.

Asenjo Lobos, C., Komossa, K., Rummel-Kluge, C., et al. (2010). Clozapine versus other atypical antipsychotics for schizophrenia. Cochrane Database of Systematic Reviews , CD006633.

Atre-Vaidya, N., Taylor, M. A. (1989). Effectiveness of lithium in schizophrenia: do we really have an answer? J Clin Psychiatry , 50, 170–3.

Ballon, J., Stroup, T. S. (2013). Polypharmacy for schizophrenia. Curr Opin Psychiatry, 26, 208.

Barnes, T. R. E., Paton, C. (2011). Antipsychotic polypharmacy in schizophrenia: benefits and risks. CNS Drugs , 25, 383–99.

Barnes, T. R. E., Leeson, V. C., Paton, C., et al. (2016). Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial. Health Technol Assess, 20, 1–46.

Bitter, I., Dossenbach, M. R., Brook, S., et al. Olanzapine HGCK Study Group. (2004). Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry, 28, 173–80.

Campbell, E., Kennedy, F., Russell, A., et al. (2014). Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers. J Neurol Neurosurg Psychiatry, 85, 1029–34.

Canadian Agency for Drugs and Technologies in Health. (2011). Optimal use recommendations for atypical antipsychotics: combination and high-dose treatment strategies in adolescents and adults with schizophrenia . Volume 1, Issue 1C. Ottawa: Canadian Agency for Drugs and Technologies in Health.

Citrome, L., (2009). Adjunctive lithium and anticonvulsants for the treatment of schizophrenia: what is the evidence? Expert Rev Neurother , 9, 55–71.

Citrome, L., Volavka, J. (2011). Pharmacological management of acute and persistent aggression in forensic psychiatry settings. CNS Drugs, 25, 1009–21.

Claus, A., Bollen, J., DeCuyper, H., et al. (1992). Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double-blind comparative study. Acta Psychiatr Scand, 85, 295–305.

Collins, P. J., Larkin, E. P., Shubsachs, A. P. (1991). Lithium carbonate in chronic schizophrenia—a brief trial of lithium carbonate added to neuroleptics for treatment of resistant schizophrenic patients. Acta Psychiatr Scand, 84, 150–4.

Conley, R. R., Tamminga, C. A., Bartko, J. J., et al. (1998). Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia. Am J Psychiatry, 155, 914–20.

Correll, C. U., Rubio, J. M., Inczedy-Farkas, G., Birnbaum, M. L., Kane, J. M., Leucht, S. (2017a). Efficacy of 42 pharmacologic cotreatment strategies added to antipsychotic monotherapy in schizophrenia: systematic overview and quality appraisal of the meta-analytic evidence. JAMA Psychiatry, 74, 675–84.

Correll, C. U., Yu, X., Xiang, Y., Kane, J. M., Masand, P. (2017b). Biological treatment of acute agitation or aggression with schizophrenia or bipolar disorder in the inpatient setting. Ann Clin Psychiatry, 29, 92–107.

Davis, J. M., Chen, N. (2004). Dose response and dose equivalence of antipsychotics. J Clin Psychopharmacol, 24, 192–208.

Dold, M., Leucht, S. (2014). Pharmacotherapy of treatment-resistant schizophrenia: a clinical perspective. Evid Based Ment Health, 17, 33–7.

Dold, M., Li, C., Gillies, D., Leucht, S. (2013). Benzodiazepine augmentation of antipsychotic drugs in schizophrenia: a meta-analysis and Cochrane review of randomized controlled trials. Eur Neuropsychopharmacol, 23, 1023–33.

Dold, M., Fugger, G.

Download

Copyright Disclaimer:
This site does not store any files on its server. We only index and link to content provided by other sites. Please contact the content providers to delete copyright contents if any and email us, we'll remove relevant links or contents immediately.